Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Confronting Hereditary Breast and Ovarian Cancer
This FORCE-endorsed book was written by founder and Executive Director Sue Friedman; geneticist Rebecca Sutphen, MD; and health writer, Kathy Steligo. This book is a comprehensive resource on all topics related to hereditary cancer, genetic testing, and risk-management.
Screening and Nonsurgical Methods of Prevention for Women at High Risk for Breast Cancer
2014 webinar by Dr. Victoria Seewaldt of Duke University on breast screening and non-surgical options for prevention for high risk women.
High-Risk Surveillance for Breast Cancer
2012 webinar on surveillance for women at high risk for breast cancer.
Breast MRI Contrast Agents
Review of research on the safety of MRI contrast agents
Nonsurgical Approaches to Hereditary Breast Cancer Risk Management
Webcast from 2010 Joining FORCE Conference presenting options for surveillance and nonsurgical prevention of breast cancer in high-risk women.
Study for Previvors Choosing Breast Surveillance: Can Exercise Lower Risk?
Article from Fall 2011 Joining FORCEs Newsletter about research examining whether exercise can lower the risk for breast cancer.
Mammograms for Young BRCA Mutation Carriers
Article from Fall 2009 Joining FORCEs Newsletter, with review of research study suggesting that mammography may hold some risks for women below the age of 30 who are undergoing high-risk screening.
FORCE Position Statement on Breast Cancer Screening Guideline Changes
FORCE response to the United States Preventive Services Task FORCE (USPSTF) guideline changes recommending: against breast self exam; changing the age of onset of mammography screening from age 40 to 50; and changing mammography screening guidelines from yearly to every 2 years.
MRI Screening for High-risk Women
Summer 2005 Joining FORCEs Newsletter article about research on the benefits of including MRI as part of high-risk surveillance for breast cancer.
Decision Tool for Women with BRCA Mutations
Developed by researchers at Stanford University, this tool is designed to help women with BRCA mutations understand the risks and survival benefits for each risk-management option in order to make the decision that is right for them.
National Comprehensive Cancer Network
Comprehensive Cancer Network is a consortium of experts in the field of oncology. The NCCN publishes a consensus guide for breast cancer high-risk women with input from the top geneticists and experts in high-risk management